Twitter | Pretraživanje | |
Ipsen
We are driven by a passion for improvement and innovation in solutions for those living with debilitating conditions. Terms of use:
1.545
Tweetovi
1.320
Pratim
4.351
Osobe koje vas prate
Tweetovi
Ipsen 13 h
Ipsen’s proprietary Precision TSI® technology is powering our groundbreaking research and development capabilities in recombinant neurotoxins. Hear more about its potential from John Chaddock and our vision for Ipsen in Neuroscience in 2020 and beyond.
Reply Retweet Označi sa "sviđa mi se"
Ipsen 17 h
Sharing learnings from a real-world case study, Pascale Cavillon, Patient Centricity Director & Jean-Charles Dhuin, Head of GMA Clinical Operations discuss why a patient-centric approach is key to successful, non-interventional studies at the 12th Annual
Reply Retweet Označi sa "sviđa mi se"
Ipsen proslijedio/la je tweet
EFPIA 4. velj
Make no mistake, we’re determined to take the big C out. So, for we’re removing the c’s
Reply Retweet Označi sa "sviđa mi se"
Ipsen 4. velj
What's it like to be diagnosed with a rare cancer? Follow us on Instagram and find out on our Stories, where we're sharing Ronny's journey for World Cancer Day:
Reply Retweet Označi sa "sviđa mi se"
Ipsen proslijedio/la je tweet
EFPIA 28. sij
We invested €8.5 billion into cancer research in 2015 and , pushing the boundaries of science to improve patient outcomes
Reply Retweet Označi sa "sviđa mi se"
Ipsen 2. velj
Since the development of our NET Symptom Index, clinicians and patient advocacy groups have approached us to integrate it in their studies, helping us further collaborate with the community. Read more:
Reply Retweet Označi sa "sviđa mi se"
Ipsen proslijedio/la je tweet
EFPIA 31. sij
Cancer mortality in children has decreased by 50% since 1995. driving innovation to help children stay healthy, so they can play, go to school and live their childhood to the fullest
Reply Retweet Označi sa "sviđa mi se"
Ipsen 31. sij
Working with patients, for patients, underlines everything we do at Ipsen. As part of our continued support of the community, we have developed a new Health Related Quality of Life tool called the NET Symptom Index to help patients and physicians manage and measure QoL.
Reply Retweet Označi sa "sviđa mi se"
Ipsen 21. sij
Problems with paywalls? Not here. We’re proud to announce that we honored our commitment to accessibility and transparency with our 100% record for open-access publication in 2019.
Reply Retweet Označi sa "sviđa mi se"
Ipsen 16. sij
Odgovor korisniku/ci @neil4jules
Hi Neil, thanks for getting in touch. The best way to reach our team is via the contact form on our UK website:
Reply Retweet Označi sa "sviđa mi se"
Ipsen 15. sij
Congratulations again to Ian Vela, recipient of our STEPS Program grant! We look forward to seeing him and all attendees this week at the 17th Meeting of the EAU Section of Oncological Urology in Dublin.
Reply Retweet Označi sa "sviđa mi se"
Ipsen 15. sij
Head of Global Business Development Oncology, Elena Ritsou, discusses how joining other leaders at the 38th J.P. Morgan Healthcare Conference helps fuel Ipsen's external innovation strategy.
Reply Retweet Označi sa "sviđa mi se"
Ipsen 15. sij
Odgovor korisniku/ci @AnandDPandyan
Information given here is referenced from the AANS: and CDC: .
Reply Retweet Označi sa "sviđa mi se"
Ipsen 15. sij
Odgovor korisniku/ci @AnandDPandyan
Hi Anand, medical professionals are always consulted on our online content. This information refers specifically to spasticity; while we note that contracture often occurs as a result of spasticity, the two conditions require different treatment.
Reply Retweet Označi sa "sviđa mi se"
Ipsen 14. sij
Here's what Eugenia Litz, Vice President Investor Relations at Ipsen, has to say about the importance of networking with industry peers at the 38th J.P. Morgan Healthcare Conference.
Reply Retweet Označi sa "sviđa mi se"
Ipsen 14. sij
Odgovor korisniku/ci @IpsenGroup
He’ll play a crucial role in delivering our global medical and patient safety strategy, engaging in structured, ethical and valuable dialogue with patients and caregivers. As a member of the ELT, Dr. Hildemann will actively contribute to the strategic direction of the company.
Reply Retweet Označi sa "sviđa mi se"
Ipsen 14. sij
We’re delighted to announce the appointment of Dr. Steven Hildemann as Executive Vice President, Chief Medical Officer and Head of Global Medical Affairs and Pharmacovigilance as of March 1st.
Reply Retweet Označi sa "sviđa mi se"
Ipsen 13. sij
Chief Executive Officer, Aymeric Le Chatelier, speaks about Ipsen's growth and trajectory for continued success on the first day of the 38th J.P. Morgan Healthcare Conference.
Reply Retweet Označi sa "sviđa mi se"
Ipsen 12. sij
Tomorrow we'll be at the the largest healthcare investment symposium in the industry, bringing together the most influential industry leaders! Stay connected to get the latest from the 38th J.P. Morgan Healthcare Conference!
Reply Retweet Označi sa "sviđa mi se"
Ipsen 8. sij
Over 75% of children with cerebral palsy experience spasticity, a muscle control disorder interfering with movement and speech. Spasticity can be particularly difficult for children, impacting the ability to perform daily tasks.
Reply Retweet Označi sa "sviđa mi se"